Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...

Novo and Valo originally partnered in September 2023 in an agreement to develop up to 11 drugs. With the expanded agreement, ...

STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

"Alison was the preeminent scholar on adolescent obesity and eating disorders,” said Kerri Boutelle, a pediatrics professor ...

A fat activist explains why she objects to the medicalization of larger bodies and the idea that obesity is a disease.

A significant percentage of adolescents in the United States are living with hyperuricemia, a condition that is associated with obesity and risks for cardiometabolic complications, according to study ...

While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...

The director of the Bariatric & Metabolic Institute at Cleveland Clinic Weston Hospital describes how you can keep up with ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

Novo Nordisk expands collaboration with Valo Health for cardiometabolic drugs and partners with Variant Bio on metabolic ...